Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by PAVEL SUMAZIN and SARAH ELSEA.
PAVEL SUMAZIN
Connection Strength
0.093
SARAH ELSEA
  1. CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I. JHEP Rep. 2025 Apr; 7(4):101327.
    View in: PubMed
    Score: 0.060
  2. Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia. Nat Commun. 2016 08 30; 7:12642.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.